Concourse Financial Group Securities’s Takeda Pharmaceutical TAK Stock Holding History

Concourse Financial Group Securities’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,281	Closed	-$145K	–	1831
2024 Q4	$145K	Sell	11,281 -1,199	-10%	-$16.5K	0.01%	831
2024 Q3	$177K	Sell	12,480 -919	-7%	-$13K	0.01%	751
2024 Q2	$173K	Buy	13,399 +12,795	+2,118%	+$169K	0.01%	732
2024 Q1	$8.39K	Buy	604 +370	+158%	+$5.38K	﹤0.01%	1759
2023 Q4	$3.34K	Sell	234 -37	-14%	-$525	﹤0.01%	1937
2023 Q3	$4.19K	Hold	271	–	–	﹤0.01%	1862
2023 Q2	$4.26K	Sell	271 -9	-3%	-$147	﹤0.01%	1872
2023 Q1	$4.61K	Hold	280	–	–	﹤0.01%	1891
2022 Q4	$4.37K	Sell	280 -1	-0.4%	-$14	﹤0.01%	1889
2022 Q3	$4K	Buy	+281	New	+$3.91K	﹤0.01%	1699
2021 Q4	–	Sell	-1,000	Closed	-$14K	–	2473
2021 Q3	$16K	Hold	1,000	–	–	﹤0.01%	1733
2021 Q2	$17K	Hold	1,000	–	–	﹤0.01%	1697
2021 Q1	$18K	Hold	1,000	–	–	﹤0.01%	1598
2020 Q4	$18K	Buy	+1,000	New	+$17.5K	﹤0.01%	1498
2019 Q4	–	Sell	-87	Closed	-$1.66K	–	2133
2019 Q3	$1K	Buy	+87	New	+$1.5K	﹤0.01%	1693
2019 Q2	–	Sell	-1,061	Closed	-$19.3K	–	2382
2019 Q1	$21K	Buy	+1,061	New	+$21.4K	﹤0.01%	1253

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Concourse Financial Group Securities's TAK Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Takeda Pharmaceutical (TAK) in Q1 2025, closing a stake of 11,281 shares — an estimated $145K sold.

Concourse Financial Group Securities first reported a position in TAK in Q1 2019 and held it in 16 quarters. The position peaked at $177K in Q3 2024. 308 funds tracked by Wall St. Rank hold TAK as of Q1 2025.

Concourse Financial Group Securities reported no remaining Takeda Pharmaceutical position as of Q1 2025 after selling out during the quarter.
Concourse Financial Group Securities sold 11,281 Takeda Pharmaceutical shares in Q1 2025, an estimated $145K.
Concourse Financial Group Securities first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 16 quarters.
Concourse Financial Group Securities's Takeda Pharmaceutical position peaked at $177K in Q3 2024.
308 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.